These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20638572)

  • 1. First-trimester screening for chromosomal abnormalities: advantages of an instant results approach.
    Norton ME
    Clin Lab Med; 2010 Sep; 30(3):565-71. PubMed ID: 20638572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of first-trimester screening for chromosomal abnormalities.
    Bahado-Singh RO; Argoti P
    Clin Lab Med; 2010 Sep; 30(3):545-55. PubMed ID: 20638570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New trends in prenatal screening for chromosomal abnormalities.
    Addar MH
    Saudi Med J; 2000 May; 21(5):429-32. PubMed ID: 11500675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal chromosomal abnormalities: antenatal screening and diagnosis.
    Anderson CL; Brown CE
    Am Fam Physician; 2009 Jan; 79(2):117-23. PubMed ID: 19178062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [First trimester ultrasound: an early screening tool for fetal structural and chromosomal abnormalities].
    Chelli D; Gaddour I; Najar I; Boudaya F; Zouaoui B; Sfar E; Chaabouni H; Chelli H; Mohamed C
    Tunis Med; 2009 Dec; 87(12):857-62. PubMed ID: 20209854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to calculating the risk of chromosomal abnormalities with first-trimester screening data.
    Merz E; Thode C; Alkier A; Eiben B; Hackelöer BJ; Hansmann M; Huesgen G; Kozlowski P; Pruggmaier M; Wellek S
    Ultraschall Med; 2008 Dec; 29(6):639-45. PubMed ID: 19085755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
    Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
    Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester screening for chromosomal abnormalities.
    Nicolaides KH
    Semin Perinatol; 2005 Aug; 29(4):190-4. PubMed ID: 16104667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester ultrasonography in screening and detection of fetal anomalies.
    Sonek J
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):45-61. PubMed ID: 17304542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal genetic screening.
    Grant SS
    Online J Issues Nurs; 2000; 5(3):2. PubMed ID: 11380268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities.
    Ritchie K; Bradbury I; Slattery J; Wright D; Iqbal K; Penney G
    BJOG; 2005 Jul; 112(7):866-74. PubMed ID: 15957985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in antenatal screening for Down syndrome.
    Wald NJ; Hackshaw AK
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester screening.
    Ellestad SC; Wells SR; Kuller JA
    Gynecol Obstet Invest; 2005; 60(1):58-62. PubMed ID: 15687731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of assessment of trisomy 21--precise risk evaluation in the first trimester of pregnancy].
    Eiben B; Hammans W; Keuter S; Goebel R; Louwen F; Epplen J
    Z Geburtshilfe Neonatol; 2001; 205(3):94-8. PubMed ID: 11474996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester prenatal diagnosis performed on pregnant women with fetal ultrasound abnormalities: the reliability of interphase fluorescence in situ hybridization (FISH) on mesenchymal core for the main aneuploidies.
    Toutain J; Epiney M; Begorre M; Dessuant H; Vandenbossche F; Horovitz J; Saura R
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):143-6. PubMed ID: 20045588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACOG Committee Opinion #296: first-trimester screening for fetal aneuploidy.
    Obstet Gynecol; 2004 Jul; 104(1):215-7. PubMed ID: 15229041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester Down syndrome screening: public health implications.
    Fuchs KM; Peipert JF
    Semin Perinatol; 2005 Aug; 29(4):267-71. PubMed ID: 16104680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.